Literature DB >> 24107772

Effects of stroke rehabilitation on incidence of poststroke depression: a population-based cohort study.

Wen-Hsuan Hou1, Huey-Wen Liang, Ching-Lin Hsieh, Chieh-Yi Hou, Pei-Chun Wen, Chung-Yi Li.   

Abstract

OBJECTIVE: To investigate the effects of rehabilitation intervention provided within the first 3 months after admission for stroke on the incidence of poststroke depression (diagnosed according to ICD-9-CM code 296, 309, or 311, or A-code A212 or A219).
METHOD: This population-based cohort study examined medical claim data of a random sample of 1 million insured people registered in 2000 in Taiwan. Between 2000 and 2005, there were 7,677 patients admitted as first-time stroke patients. Of these, 1,285 (16.7%) received a rehabilitation regimen within the first 3 months of admission for stroke. The other 83.3% of patients (n = 6,482) belonged to the control group. All study subjects were followed to the end of 2009 to identify any ambulatory treatment for depression as the end point. The incidence density of poststroke depression was calculated assuming a Poisson process. A Cox proportional hazard model was used to estimate the relative risk of poststroke depression in relation to receipt of rehabilitation.
RESULTS: Over a 10-year follow-up, 75 patients (5.8%) with rehabilitation and 566 controls (8.7%) developed poststroke depression, representing incidence densities of 11.3 and 18.5 per 1,000 person-years, respectively. After analyses were controlled for potential confounders, rehabilitation was found to significantly reduce the risk of poststroke depression, with a hazard ratio (HR) of 0.57 (95% CI, 0.45-0.73). The effect was greater for men (HR = 0.52; 95% CI, 0.37-0.71), especially for elderly men (HR = 0.45; 95% CI, 0.28-0.71), than for women (HR = 0.69; 95% CI, 0.47-1.02).
CONCLUSIONS: Stroke rehabilitation intervention in the first 3 months after admission for stroke may significantly reduce the risk of poststroke depression. Although this beneficial effect appears to be greater for men than for women, clinicians should also be alert for poststroke depression occurring in women. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24107772     DOI: 10.4088/JCP.12m08259

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

1.  Ameliorative effect of Xiaoyao-jieyu-san on post-stroke depression and its potential mechanisms.

Authors:  Changde Wang; Chunlan Wu; Zhenguo Yan; Xiao Cheng
Journal:  J Nat Med       Date:  2018-09-07       Impact factor: 2.343

2.  Increasing Access to Cost Effective Home-Based Rehabilitation for Rural Veteran Stroke Survivors.

Authors:  S N Housley; A R Garlow; K Ducote; A Howard; T Thomas; D Wu; K Richards; A J Butler
Journal:  Austin J Cerebrovasc Dis Stroke       Date:  2016-08-25

3.  Improving Quality of Life and Depression After Stroke Through Telerehabilitation.

Authors:  Susan M Linder; Anson B Rosenfeldt; R Curtis Bay; Komal Sahu; Steven L Wolf; Jay L Alberts
Journal:  Am J Occup Ther       Date:  2015 Mar-Apr

4.  Racial Variation in the Association Between Domains of Depressive Symptomatology and Functional Recovery in Stroke Survivors.

Authors:  Stephen C L Lau; Bettina F Drake; Vetta L Sanders-Thompson; Carolyn M Baum
Journal:  J Racial Ethn Health Disparities       Date:  2022-04-04

5.  Predictors of poststroke health-related quality of life in Nigerian stroke survivors: a 1-year follow-up study.

Authors:  Ashiru Mohammad Hamza; Nabilla Al-Sadat; Siew Yim Loh; Nowrozy Kamar Jahan
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

6.  A Population-Based Cohort Study on the Ability of Acupuncture to Reduce Post-Stroke Depression.

Authors:  Shuo-Ping Tseng; Yu-Ching Hsu; Ching-Ju Chiu; Shang-Te Wu
Journal:  Medicines (Basel)       Date:  2017-03-15

Review 7.  The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression.

Authors:  Simeng Gu; Zhengming He; Qiuyue Xu; Jie Dong; Tingwei Xiao; Fei Liang; Xianjun Ma; Fushun Wang; Jason H Huang
Journal:  Front Psychiatry       Date:  2022-04-26       Impact factor: 5.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.